_version_ 1784640218008125440
author Zátopková, Martina
Ševčíková, Tereza
Fanfani, Viola
Chyra, Zuzana
Říhová, Lucie
Bezděková, Renata
Žihala, David
Growková, Kateřina
Filipová, Jana
Černá, Lucie
Broskevičova, Lucie
Kryukov, Fedor
Minařík, Jiří
Smejkalová, Jana
Maisnar, Vladimír
Harvanová, Ĺubica
Pour, Luděk
Jungova, Alexandra
Popková, Tereza
Bago, Juli Rodriguez
Anilkumar Sithara, Anjana
Hrdinka, Matouš
Jelínek, Tomáš
Šimíček, Michal
Stracquadanio, Giovanni
Hájek, Roman
author_facet Zátopková, Martina
Ševčíková, Tereza
Fanfani, Viola
Chyra, Zuzana
Říhová, Lucie
Bezděková, Renata
Žihala, David
Growková, Kateřina
Filipová, Jana
Černá, Lucie
Broskevičova, Lucie
Kryukov, Fedor
Minařík, Jiří
Smejkalová, Jana
Maisnar, Vladimír
Harvanová, Ĺubica
Pour, Luděk
Jungova, Alexandra
Popková, Tereza
Bago, Juli Rodriguez
Anilkumar Sithara, Anjana
Hrdinka, Matouš
Jelínek, Tomáš
Šimíček, Michal
Stracquadanio, Giovanni
Hájek, Roman
author_sort Zátopková, Martina
collection PubMed
description
format Online
Article
Text
id pubmed-8791596
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-87915962022-01-27 Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine Zátopková, Martina Ševčíková, Tereza Fanfani, Viola Chyra, Zuzana Říhová, Lucie Bezděková, Renata Žihala, David Growková, Kateřina Filipová, Jana Černá, Lucie Broskevičova, Lucie Kryukov, Fedor Minařík, Jiří Smejkalová, Jana Maisnar, Vladimír Harvanová, Ĺubica Pour, Luděk Jungova, Alexandra Popková, Tereza Bago, Juli Rodriguez Anilkumar Sithara, Anjana Hrdinka, Matouš Jelínek, Tomáš Šimíček, Michal Stracquadanio, Giovanni Hájek, Roman Blood Adv Commentary American Society of Hematology 2022-01-13 /pmc/articles/PMC8791596/ /pubmed/34500459 http://dx.doi.org/10.1182/bloodadvances.2020003876 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
spellingShingle Commentary
Zátopková, Martina
Ševčíková, Tereza
Fanfani, Viola
Chyra, Zuzana
Říhová, Lucie
Bezděková, Renata
Žihala, David
Growková, Kateřina
Filipová, Jana
Černá, Lucie
Broskevičova, Lucie
Kryukov, Fedor
Minařík, Jiří
Smejkalová, Jana
Maisnar, Vladimír
Harvanová, Ĺubica
Pour, Luděk
Jungova, Alexandra
Popková, Tereza
Bago, Juli Rodriguez
Anilkumar Sithara, Anjana
Hrdinka, Matouš
Jelínek, Tomáš
Šimíček, Michal
Stracquadanio, Giovanni
Hájek, Roman
Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine
title Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine
title_full Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine
title_fullStr Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine
title_full_unstemmed Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine
title_short Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine
title_sort mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791596/
https://www.ncbi.nlm.nih.gov/pubmed/34500459
http://dx.doi.org/10.1182/bloodadvances.2020003876
work_keys_str_mv AT zatopkovamartina mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT sevcikovatereza mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT fanfaniviola mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT chyrazuzana mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT rihovalucie mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT bezdekovarenata mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT zihaladavid mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT growkovakaterina mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT filipovajana mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT cernalucie mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT broskevicovalucie mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT kryukovfedor mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT minarikjiri mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT smejkalovajana mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT maisnarvladimir mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT harvanovalubica mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT pourludek mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT jungovaalexandra mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT popkovatereza mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT bagojulirodriguez mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT anilkumarsitharaanjana mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT hrdinkamatous mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT jelinektomas mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT simicekmichal mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT stracquadaniogiovanni mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine
AT hajekroman mutationlandscapeofmultiplemyelomameasurableresidualdiseaseidentificationoftargetsforprecisionmedicine